Alwyn Forbes
About Alwyn Forbes
Alwyn Forbes is a Senior Scientist at Bristol Myers Squibb in the Greater New York City Area with extensive experience in pharmaceutical research and development.
Current Role at Bristol Myers Squibb
Alwyn Forbes is currently serving as a Senior Scientist at Bristol Myers Squibb in the Greater New York City Area. He leverages his extensive background and expertise in the pharmaceutical industry to lead and contribute to scientific research and development.
Career at Celgene
Alwyn Forbes has had a notable career at Celgene, where he held multiple positions. From 2011 to 2020, he advanced through the ranks, starting as an Associate Scientist and achieving roles such as Sr Associate Scientist from 2014 to 2018 and Research Scientist from 2018 to 2020. His work primarily took place in Summit, NJ, where he contributed significantly to various research initiatives.
Educational Background
Alwyn Forbes has a strong educational background with multiple degrees. He earned a Bachelor's in Chemistry from Florida International University between 1993 and 1996. He continued his education with an MBA, also from Florida International University, from 2004 to 2007. Additionally, he obtained a Master of Business and Science with a focus on Drug Discovery & Development from Rutgers University-New Brunswick, from 2014 to 2017.
Previous Positions and Experience
Alwyn Forbes's career includes a variety of roles across different organizations. He worked as a Scientist II at Kos Pharmaceuticals from 2003 to 2007 and as a Research Assistant at Temple University from 2001 to 2002. His experience also includes consulting roles at Vyteris and Wyeth Pharmaceuticals, and research positions such as Research Chemist at Intertek Caleb Brett and Chemist III at Azopharma Contract Pharmaceutical.
Expertise in LC-MS and GLP
Alwyn Forbes is recognized for his expertise in Liquid Chromatography-Mass Spectrometry (LC-MS) and Good Laboratory Practice (GLP). His skills in these areas have contributed to his success in various scientific and research roles throughout his career. Additionally, he has a strong background in Validation and GMP, critical components in the pharmaceutical and biotechnology industries.